Pfizer facing financial pressure after axed drug trial

Pfizer, the world’s largest pharmaceutical manufacturer, will be forced to shed staff and speed up merger and licensing deals, analysts say, after the company ended trials of a key cholesterol drug.

The analysts differed on how much they believed Pfizer stock would fall when it opened today.